Local thrombolytic therapy in superior vena cava syndrome secondary to malignant thymoma: a case report and literature review

Superior vena caval (SVC) obstruction due to malignant thymoma is exceedingly uncommon. We report a case of SVC syndrome where local intravenous thrombolytic therapy uncovered an SVC tumor mass not detected by high resolution computed tomography or magnetic resonance imaging scanning. Local intraven...

Full description

Saved in:
Bibliographic Details
Published inCatheterization and cardiovascular diagnosis Vol. 31; no. 3; p. 215
Main Authors Enders, G C, Sodums, M T
Format Journal Article
LanguageEnglish
Published United States 01.03.1994
Subjects
Aged
Humans
Male
Neoplastic Cells, Circulating
Subclavian Vein
Superior Vena Cava Syndrome - drug therapy
Superior Vena Cava Syndrome - etiology
Thrombolytic Therapy - methods
Thymoma - complications
Thymus Neoplasms - complications
Urokinase-Type Plasminogen Activator - administration & dosage
Urokinase-Type Plasminogen Activator - therapeutic use
Online AccessGet more information

Cover

More Information
Summary:Superior vena caval (SVC) obstruction due to malignant thymoma is exceedingly uncommon. We report a case of SVC syndrome where local intravenous thrombolytic therapy uncovered an SVC tumor mass not detected by high resolution computed tomography or magnetic resonance imaging scanning. Local intravenous thrombolytic therapy may be therapeutic in central venous obstruction and may facilitate the diagnosis of the underlying cause of obstruction.
ISSN:0098-6569
DOI:10.1002/ccd.1810310311